“Leronlimab monotherapy (700 mg) demonstrated st
Post# of 148101
(Total Views: 517)
Posted On: 09/24/2024 4:12:07 PM
“Leronlimab monotherapy (700 mg) demonstrated statistically significant fibrosis reversal compared to an isotype IgG4 control arm (p<0.01)”
This has to be emphasized, we are talking about fibrosis REVERSAL. This is huge. There were hints of this from the phase 2 study in humans. I am fairly confident Dr Jay and Cytodyn will shop these results around and they should generate interest. Madrigal may have justification to be nervous if another BP gets ahold of Leronlimab. Their one trick pony might get put out to pasture.
This has to be emphasized, we are talking about fibrosis REVERSAL. This is huge. There were hints of this from the phase 2 study in humans. I am fairly confident Dr Jay and Cytodyn will shop these results around and they should generate interest. Madrigal may have justification to be nervous if another BP gets ahold of Leronlimab. Their one trick pony might get put out to pasture.
(21)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼